Amundi Asset Management US’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Amundi Asset Management US’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$333K	Hold	4,800	–	–	﹤0.01%	1392
2020 Q4	$369K	Hold	4,800	–	–	﹤0.01%	1346
2020 Q3	$359K	Hold	4,800	–	–	﹤0.01%	1297
2020 Q2	$302K	Hold	4,800	–	–	﹤0.01%	1324
2020 Q1	$202K	Hold	4,800	–	–	﹤0.01%	1330
2019 Q4	$218K	Hold	4,800	–	–	﹤0.01%	1450
2019 Q3	$220K	Buy	4,800 +1,000	+26%	+$56.2K	﹤0.01%	1439
2019 Q2	$223K	Hold	3,800	–	–	﹤0.01%	1462
2019 Q1	$170K	Hold	3,800	–	–	﹤0.01%	1463
2018 Q4	$148	Buy	+3,800	New	+$149K	﹤0.01%	1437

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Amundi Asset Management US's ARNA Position: Q1 2021 in Review

Amundi Asset Management US held its Arena Pharmaceuticals Inc (ARNA) position steady in Q1 2021 at 4,800 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

Amundi Asset Management US first reported a position in ARNA in Q4 2018 and has held it in 10 quarters since. The position peaked at $369K in Q4 2020. 235 funds tracked by Wall St. Rank hold ARNA as of Q1 2021.

Amundi Asset Management US held 4,800 shares of Arena Pharmaceuticals Inc worth $333K as of Q1 2021.
Amundi Asset Management US left its Arena Pharmaceuticals Inc share count unchanged in Q1 2021.
Arena Pharmaceuticals Inc made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1392 holding.
Amundi Asset Management US first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and has held it in 10 quarters since.
Amundi Asset Management US's Arena Pharmaceuticals Inc position peaked at $369K in Q4 2020.
235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.